Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What the Clinical Trial Evidence Shows Phase 2 retatrutide trial data reported gastrointestinal effects as the most common adverse events
The compound is stable at pH 5.5-7.0 and should not be mixed with chelating agents (EDTA) that would strip the copper ion
IV delivery maximizes absorption for results you can see
If youre looking for a little inspiration, head to PCOS Lunch Recipes to Add to Your Meal Plan! Prioritize strength training with weight loss
Other Potential Concerns Rare but serious adverse effects include pancreatitis (presenting as severe abdominal pain), gallbladder disease, and potential thyroid effects
However, worth noting, Retatrutide remains a research compound only , it isnt approved for any therapeutic use, and all comparisons refer strictly to pre-clinical research findings
